NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
-25.08%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$430M
AUM Growth
+$430M
(-30%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
95.16%
Holding
15
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $269M | 62.46% |
7,601,087
| – | – |
|
2
Tyra Biosciences
TYRA
$675M
| $37.7M | 8.77% |
4,055,861
| – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $29.5M | 6.85% |
5,285,714
| – | – |
|
4
Zymeworks
ZYME
$1.12B
| $13.3M | 3.08% |
1,113,946
| – | – |
|
5
ARS Pharmaceuticals
SPRY
$1.15B
| $11.8M | 2.74% |
936,729
| – | – |
|
|
CRGX
6
DELISTED
CARGO Therapeutics
CRGX
| $10.8M | 2.5% |
2,642,502
| – | – |
|
7
Relay Therapeutics
RLAY
$619M
| $10.1M | 2.34% |
3,846,409
| – | – |
|
8
Arvinas
ARVN
$568M
| $9.89M | 2.3% |
1,408,394
| – | – |
|
|
ALMS
9
Alumis Inc. Common Stock
ALMS
$479M
| $9.07M | 2.11% |
1,476,998
| – | – |
|
10
Cullinan Oncology
CGEM
$445M
| $8.64M | 2.01% |
1,141,145
| – | – |
|
11
Tango Therapeutics
TNGX
$747M
| $7.58M | 1.76% |
5,533,980
| – | – |
|
12
Context Therapeutics
CNTX
$75.4M
| $4.54M | 1.06% |
7,419,355
| – | – |
|
13
Mersana Therapeutics
MRSN
$36.5M
| $4.15M | 0.97% |
12,067,246
| – | – |
|
|
SLN
14
Silence Therapeutics
SLN
$227M
| $2.69M | 0.62% |
952,400
| – | – |
|
|
BOLD
15
Boundless Bio
BOLD
$25.1M
| $1.85M | 0.43% |
1,228,069
| – | – |
|